Revlimid Sert Capsule 25 Mg

Description

Composition and Packaging

Each capsule contains a potent 25 mg of Lenalidomide, with packaging in sets of 21 capsules.

Availability

For urgent circumstances related to this product, visit the Urgent Quotation page. Any pharmaceutical queries can be addressed in the comments section.

Manufacturer

Manufactured by Celgene in Switzerland, this medication stands as a testament to advanced pharmaceutical expertise.

Note: The provided information is sourced from available resources and may not encompass the full scope. Always seek advice from a healthcare professional for comprehensive medical guidance.

How it Works?

Revlimid Sert Capsule 25 Mg, enriched with the active drug Lenalidomide, operates as an immunomodulator. This entails enhancing the immune system’s capacity to combat the proliferation of cancer cells. The mechanisms behind its functionality are multifaceted:

Immune System Stimulation

Revlimid influences the body’s immune system, promoting immune responses that impede tumor growth. This is achieved by activating a section of the immune system to target and attack cancer cells.

Direct Attack on Cancer Cells

In addition to immune stimulation, Revlimid directly combats cancer cells by inhibiting their development.

Inhibition of Blood Vessel Growth

Revlimid’s efficacy extends to halting the growth of blood vessels in cancerous regions. This disruption in blood supply to cancer cells contributes to slowing down or inhibiting their growth.

Uses

Revlimid finds application in the treatment of multiple myeloma, either in conjunction with other medications or post-stem cell transplant. It is also effective in addressing anemia in patients with myelodysplastic syndrome, specifically deletion 5q MDS. Additionally, it serves as a treatment for mantle cell lymphoma, a rare form of lymph node cancer, after previous medications prove unsuccessful.

Note: The information provided serves as a general overview. For tailored medical advice, consult a healthcare professional.

Side Effects

Revlimid Sert Capsule 25 Mg, housing Lenalidomide as the active ingredient, may elicit both mild and severe side effects. An intricate exploration reveals potential manifestations:

Common Side Effects

1. Diarrhea
2. Fatigue (low energy)
3. Decreased blood cell levels
4. Constipation
5. Skin rash or itchiness
6. Insomnia (trouble sleeping)
7. Edema (swelling due to excess fluid)
8. Weakness and dizziness
9. Nausea or vomiting
10. Fever
11. Respiratory infections
12. Gastroenteritis (stomach flu)
13. Cough
14. Shortness of breath
15. Pain in back or joints
16. Headache
17. Muscle cramps
18. Nosebleeds

Serious Side Effects

While infrequent, serious side effects can include:

1. Prickling or tingling sensations
2. Numbness
3. Pain
4. Muscle cramping, twitching, or weakness
5. Significant neutropenia and thrombocytopenia
6. Deep vein thrombosis (DVT) and pulmonary embolism (PE)
7. Myocardial infarction and stroke

Note: The information is drawn from available resources. For personalized medical advice, consult a healthcare professional.

Administration

Administered orally, Revlimid Sert Capsule 25 Mg entails a once-daily consumption with water. The dosing cycle, particularly when combined with dexamethasone, adheres to a 28-day schedule:

• Revlimid 25 mg daily for 21 days
• Dexamethasone 40 mg on days 1, 8, 15, and 22

Note: The details provided are based on available resources. Consult a healthcare professional for individualized medical guidance.

Benefits of Revlimid Sert Capsule 25 Mg

Revlimid Sert Capsule 25 Mg, housing Lenalidomide, operates as an immunomodulator, redefining its benefits:

Immune System Stimulation

Stimulation of the immune system, triggering responses from T cells, vital in cell-mediated immunity.

Inhibition of Pro-Inflammatory Cytokines

Revlimid inhibits the release of pro-inflammatory cytokines, influencing cell behavior in the surrounding environment.

Direct Attack on Cancer Cells

Beyond immune stimulation, Revlimid directly impedes cancer cells’ development.

Inhibition of Blood Vessel Growth

Revlimid prevents blood vessel growth in cancerous regions, curtailing the blood supply to impede or halt cell growth.

Note: The information provided serves as a general overview. For tailored medical advice, consult a healthcare professional.

Can I Take This Medication With Food?

Revlimid Sert Capsule 25 Mg, featuring Lenalidomide, is typically administered orally. However, specific instructions regarding food intake can vary. Some medications exhibit enhanced efficacy with food, while others necessitate ingestion on an empty stomach. Adhering to the guidance of your healthcare provider or pharmacist is essential. If uncertain, seek clarification on whether food intake is advisable.

Note: The information is sourced from available resources and may not be fully comprehensive. Always consult with a healthcare professional for medical advice.

Conclusion

In conclusion, Revlimid Sert Capsule 25 Mg, a creation of Celgene, presents a formidable solution in the realm of pharmaceutical interventions. Its efficacy in multiple myeloma, myelodysplastic syndrome, and mantle cell lymphoma underscores its significance. However, individual responses and considerations may vary, necessitating the guidance of healthcare professionals for personalized medical advice.

---

Feature	Revlimid Sert Capsule 25 Mg
Composition	25 mg Lenalidomide
Dosage and Packaging	25 mg potency, 21 capsules per pack
Availability	Urgent Quotation page for emergencies, comments for pharmaceutical questions
Manufacturer	Celgene, Switzerland
Mechanism of Action	Immunomodulator boosting immune system to combat cancer cells
Common Side Effects	Diarrhea, fatigue, decreased blood cell levels, constipation, skin rash, insomnia, edema, weakness, dizziness, nausea, vomiting, fever, respiratory infections, gastroenteritis, cough, shortness of breath, pain in back or joints, headache, muscle cramps, nosebleeds
Serious Side Effects	Prickling or tingling sensations, numbness, pain, muscle cramping, significant neutropenia and thrombocytopenia, deep vein thrombosis (DVT) and pulmonary embolism (PE), myocardial infarction, stroke
Administration	Orally, once-daily capsule with water
Dosing Cycle	Revlimid 25 mg daily for 21 days, Dexamethasone 40 mg on days 1, 8, 15, and 22
Drug Interactions	263 known interactions categorized as major, moderate, or minor; Examples include Acyclovir, Allopurinol, Amlodipine, Aspirin, Dexamethasone, Folic acid, Furosemide, Gabapentin, Levothyroxine, Lisinopril, Losartan, Metformin, Metoprolol, Omeprazole, Ondansetron, Oxycodone, Pantoprazole, Prednisone, Tamsulosin, Tylenol (acetaminophen), Vitamin B12 (cyanocobalamin), Vitamin D3 (cholecalciferol)
Disease Interactions	Renal impairment, Thromboembolic events, Anemia
Uses	Treatment of multiple myeloma, anemia in myelodysplastic syndrome, mantle cell lymphoma after unsuccessful prior medications
Food Interaction	Instructions may vary; consult healthcare provider or pharmacist